反应 #1869195

ord-22eb2861c23d43d680bdd14f2f88c5d2

反应方程式

CC(C)(C)OC(=O)N1CC[C@H](NCc2ccccc2)[C@H](F)C1
cis-4-benzylamino-1-tert-butoxycarbonyl-3-fluoropiperidine
Cl
HCl
CC(C)(C)OC(=O)N1CC[C@@H](N)[C@@H](F)C1
title compound
收率 53.0%
CC(C)(C)OC(=O)N1CC[C@@H](N)[C@@H](F)C1
(3S, 4R)-4-Amino-1-tert-butoxycarbonyl-3-fluoropiperidine
收率 53.0%

溶剂

反应条件

详细条件
See reaction.notes.procedure_details.

后处理

  1. 1
    其他prepared
  2. 2
    过滤was filtered through Celite®
  3. 3
    浓缩The filtrate was concentrated under reduced pressure
  4. 4
    其他the residue was purified by flash chromatography on silica gel (10% MeOH/CHCl3)

实验过程

To a solution of the enantiomeric mixture of cis-4-benzylamino-1-tert-butoxycarbonyl-3-fluoropiperidine (prepared according to the procedures of J. Med. Chem. 1999, 42, 2087-2104, 1.0 g, 3.2 mmole) in EtOH (40 mL) was added 3 N HCl (2.5 L) and 10% Pd/C (50 mg). The reaction was shaken under H2 (40 psi) on a Parr apparatus for 14 h, then was filtered through Celite®. The filtrate was concentrated under reduced pressure, and the residue was purified by flash chromatography on silica gel (10% MeOH/CHCl3) to afford the title compound (370 mg, 53%) as a white solid.

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US07498326B2uspto-grants-2009_03